- Home
- SOND vs TENX Comparison
SOND vs TENX Comparison
Compare SOND & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOND
- TENX
- Stock Information
- Founded
- SOND 2014
- TENX 1967
- Country
- SOND United States
- TENX United States
- Employees
- SOND N/A
- TENX N/A
- Industry
- SOND Hotels/Resorts
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- SOND Consumer Discretionary
- TENX Health Care
- Exchange
- SOND Nasdaq
- TENX Nasdaq
- Market Cap
- SOND 27.0M
- TENX 25.0M
- IPO Year
- SOND N/A
- TENX N/A
- Fundamental
- Price
- SOND $1.91
- TENX $6.00
- Analyst Decision
- SOND
- TENX Strong Buy
- Analyst Count
- SOND 0
- TENX 3
- Target Price
- SOND N/A
- TENX $15.00
- AVG Volume (30 Days)
- SOND 22.0K
- TENX 20.8K
- Earning Date
- SOND 07-23-2025
- TENX 08-13-2025
- Dividend Yield
- SOND N/A
- TENX N/A
- EPS Growth
- SOND N/A
- TENX N/A
- EPS
- SOND N/A
- TENX N/A
- Revenue
- SOND $621,272,000.00
- TENX N/A
- Revenue This Year
- SOND $46.47
- TENX N/A
- Revenue Next Year
- SOND N/A
- TENX N/A
- P/E Ratio
- SOND N/A
- TENX N/A
- Revenue Growth
- SOND 3.19
- TENX N/A
- 52 Week Low
- SOND $1.47
- TENX $3.25
- 52 Week High
- SOND $10.50
- TENX $7.89
- Technical
- Relative Strength Index (RSI)
- SOND 36.18
- TENX 50.43
- Support Level
- SOND $1.80
- TENX $5.87
- Resistance Level
- SOND $2.04
- TENX $6.02
- Average True Range (ATR)
- SOND 0.10
- TENX 0.17
- MACD
- SOND -0.01
- TENX -0.01
- Stochastic Oscillator
- SOND 31.23
- TENX 46.81
About SOND Sonder Holdings Inc.
Sonder Holdings Inc is engaged in providing short and long-term accommodations to travelers in various cities across North America, Europe, and the Middle East. The Sonder units in each apartment-style building and each hotel property are selected, designed, and managed directly by the Company. The Company generates revenues by providing short-term or month-to-month accommodations to its guests. The Company also provides accommodations to travelers through boutique hotels.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.